|
US5252334A
(en)
*
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
US6407082B1
(en)
*
|
1996-09-13 |
2002-06-18 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a vitamin D compound
|
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
|
PL181582B1
(pl)
*
|
1995-06-07 |
2001-08-31 |
Ortho Mcneil Pharm Inc |
Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
|
|
US6028064A
(en)
|
1996-09-13 |
2000-02-22 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of progestin products
|
|
US6765002B2
(en)
|
2000-03-21 |
2004-07-20 |
Gustavo Rodriguez |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
|
|
US6034074A
(en)
|
1996-09-13 |
2000-03-07 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a Vitamin D compound
|
|
US6511970B1
(en)
|
1996-09-13 |
2003-01-28 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
|
|
US6248358B1
(en)
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
|
US6624200B2
(en)
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
|
DE19834007C1
(de)
*
|
1998-07-29 |
2000-02-24 |
Lohmann Therapie Syst Lts |
Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen und seine Verwendung
|
|
WO2000024377A1
(en)
*
|
1998-10-23 |
2000-05-04 |
Idea Innovative Dermale Applikationen Gmbh |
Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
|
|
US6984404B1
(en)
|
1998-11-18 |
2006-01-10 |
University Of Florida Research Foundation, Inc. |
Methods for preparing coated drug particles and pharmaceutical formulations thereof
|
|
AU2051600A
(en)
*
|
1998-12-10 |
2000-06-26 |
Board Of Regents, The University Of Texas System |
Compositions and methods of modulating cholesterol metabolism
|
|
EP1031347B1
(de)
|
1999-01-27 |
2002-04-17 |
Idea Ag |
Transnasaler Transport bzw. Impfung mit hochadaptierbaren Trägern
|
|
EP1031346B1
(de)
|
1999-01-27 |
2002-05-02 |
Idea Ag |
Nichtinvasive Impfung durch die Haut
|
|
US6297337B1
(en)
|
1999-05-19 |
2001-10-02 |
Pmd Holdings Corp. |
Bioadhesive polymer compositions
|
|
EP1754488A1
(de)
|
1999-05-24 |
2007-02-21 |
Introgen Therapeutics, Inc. |
Verfahren und Zusammensetzungen für nichtvirale Gentherapie zur Behandlung von hyperproliferativen Krankheiten
|
|
US6406745B1
(en)
*
|
1999-06-07 |
2002-06-18 |
Nanosphere, Inc. |
Methods for coating particles and particles produced thereby
|
|
WO2001001962A1
(en)
*
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
US20010044431A1
(en)
*
|
2000-03-21 |
2001-11-22 |
Rodriguez Gustavo C. |
Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
|
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
AU5378201A
(en)
|
2000-04-26 |
2001-11-07 |
Watson Pharmaceuticals Inc |
Minimizing adverse experience associated with oxybutynin therapy
|
|
US10293056B1
(en)
|
2000-05-24 |
2019-05-21 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
WO2003013611A1
(fr)
*
|
2001-08-10 |
2003-02-20 |
Hisamitsu Pharmaceutical Co., Inc. |
Preparations a absorption par voie cutanee
|
|
KR20030041596A
(ko)
*
|
2001-11-20 |
2003-05-27 |
삼일페인트공업 주식회사 |
의료용 팻치에 적용되는 아크릴 점착제의 제조방법
|
|
US7921999B1
(en)
|
2001-12-20 |
2011-04-12 |
Watson Laboratories, Inc. |
Peelable pouch for transdermal patch and method for packaging
|
|
US7473432B2
(en)
*
|
2002-10-11 |
2009-01-06 |
Idea Ag |
NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
|
|
GB0409498D0
(en)
*
|
2004-04-28 |
2004-06-02 |
Hunter Fleming Ltd |
Transdermal steroid formulation
|
|
CA2584475A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Idea Ag |
Extended surface aggregates in the treatment of skin conditions
|
|
US7833979B2
(en)
*
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
US10137135B2
(en)
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
|
RS52671B
(sr)
|
2005-10-12 |
2013-06-28 |
Unimed Pharmaceuticals Llc |
Poboljšani gel testosterona i postupak korišćenja
|
|
CA2630840A1
(en)
*
|
2005-11-23 |
2007-05-31 |
Universitaet Zuerich |
Allergy treatment by epicutaneous allergen administration
|
|
CN101370453B
(zh)
*
|
2005-12-14 |
2013-12-18 |
努沃研究公司 |
用于皮肤输送药物的组合物和方法
|
|
WO2007092944A2
(en)
*
|
2006-02-08 |
2007-08-16 |
Introgen Therapeutics, Inc. |
Compositions and methods involving gene therapy and proteasome modulation
|
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
|
PE20081140A1
(es)
*
|
2006-10-25 |
2008-09-22 |
Amgen Inc |
Agentes terapeuticos a base de peptidos derivados de toxinas
|
|
WO2008106646A2
(en)
*
|
2007-03-01 |
2008-09-04 |
Introgen Therapeutics, Inc |
Methods and formulations for topical gene therapy
|
|
DK2623605T3
(en)
|
2007-04-09 |
2019-03-25 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
|
MX2009012609A
(es)
|
2007-05-22 |
2009-12-07 |
Amgen Inc |
Composiciones y metodos para producir proteinas de fusion bioactivas.
|
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
|
CA2697373C
(en)
|
2007-08-27 |
2019-05-21 |
Longhorn Vaccines & Diagnostics, Llc |
Immunogenic compositions and methods
|
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
|
AU2008343745B2
(en)
|
2007-10-01 |
2012-05-10 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection and transport system and methods of use
|
|
WO2010135714A2
(en)
|
2009-05-22 |
2010-11-25 |
The Methodist Hospital Research Institute |
Methods for modulating adipocyte expression using microrna compositions
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
HUE041571T2
(hu)
|
2010-04-23 |
2019-05-28 |
Univ Florida |
RAAV-guanilát-cikláz-készítmények és ejárások 1-es típusú Leber-féle veleszületett vakság (LCA1) kezelésére
|
|
DK2561073T3
(en)
|
2010-04-23 |
2016-12-12 |
Univ Massachusetts |
Aav vectors targeted to central nervous system and methods of use thereof
|
|
CA2833912C
(en)
|
2010-04-23 |
2021-09-21 |
University Of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
PH12013501865A1
(en)
|
2011-03-16 |
2014-01-06 |
Amgen Inc |
Potent and selective inhibitors of nav1.3 and nav1.7
|
|
WO2012145624A2
(en)
|
2011-04-21 |
2012-10-26 |
University Of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
JP6104173B2
(ja)
|
2011-12-01 |
2017-03-29 |
帝國製薬株式会社 |
ロピニロール含有貼付剤
|
|
US10149834B2
(en)
|
2011-12-01 |
2018-12-11 |
Teikoku Seiyaku Co., Ltd. |
Ropinirole-containing adhesive patch
|
|
CA3207612A1
(en)
|
2012-01-26 |
2013-08-01 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
WO2014165277A2
(en)
|
2013-03-12 |
2014-10-09 |
Amgen Inc. |
POTENT AND SELECTIVE INHIBITORS OF Nav1.7
|
|
JP6756700B2
(ja)
|
2014-03-18 |
2020-09-16 |
ユニバーシティ オブ マサチューセッツ |
筋萎縮性側索硬化症を処置するためのrAAVベースの組成物および方法
|
|
WO2015164786A1
(en)
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
WO2016054557A1
(en)
|
2014-10-03 |
2016-04-07 |
University Of Massachusetts |
Novel high efficiency library-identified aav vectors
|
|
WO2016065001A1
(en)
|
2014-10-21 |
2016-04-28 |
University Of Massachusetts |
Recombinant aav variants and uses thereof
|
|
JP6754361B2
(ja)
|
2014-12-16 |
2020-09-09 |
ボード オブ リージェンツ オブ ザ ユニバーシティ オブ ネブラスカ |
若年型バッテン病のための遺伝子療法
|
|
EP3285788B1
(de)
|
2015-04-23 |
2024-12-18 |
University of Massachusetts |
Modulation der transgenexpression eines aav-vektors
|
|
EP3294448A4
(de)
|
2015-05-14 |
2018-12-12 |
Longhorn Vaccines and Diagnostics, LLC |
Schnellverfahren zur extraktion von nukleinsäuren aus biologischen proben
|
|
ES2902477T3
(es)
|
2015-12-04 |
2022-03-28 |
Univ Texas |
Péptidos SLC45A2 para inmunoterapia
|
|
CA3011939A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
IL261524B2
(en)
|
2016-03-03 |
2023-10-01 |
Univ Massachusetts |
End-capped linear double-stranded DNA for non-viral gene transfer
|
|
WO2018039375A1
(en)
|
2016-08-23 |
2018-03-01 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
KR20190075964A
(ko)
|
2016-10-13 |
2019-07-01 |
유니버시티 오브 매사추세츠 |
Aav 캡시드 설계
|
|
US11318190B2
(en)
|
2017-05-05 |
2022-05-03 |
United States Government As Represented By The Department Of Veterans Affairs |
Methods and compositions for treating liver disease
|
|
WO2019075385A1
(en)
|
2017-10-12 |
2019-04-18 |
Board Of Regents, The University Of Texas System |
T-LYMPHOCYTE COMPOSITIONS FOR IMMUNOTHERAPY
|
|
US12441998B2
(en)
|
2017-10-12 |
2025-10-14 |
The Trustees Of Columbia University In The City Of New York |
SLC2A1 lncRNA as a biologic and related treatments and methods
|
|
IL325122A
(en)
|
2018-02-22 |
2026-02-01 |
Akouos Inc |
Compositions and methods for treating non-age-related hearing impairment in humans
|
|
EP4169576A1
(de)
|
2018-03-23 |
2023-04-26 |
University of Massachusetts |
Gentherapeutika zur behandlung von knochenerkrankungen
|
|
BR112020021324A2
(pt)
|
2018-04-18 |
2021-01-19 |
The Trustees Of Columbia University In The City Of New York |
Terapia gênica para doenças causadas por pools de nucleotídeos em desequilíbrio incluindo síndromes de depleção do dna mitocondrial
|
|
CA3098448A1
(en)
|
2018-04-27 |
2019-10-31 |
University Of Massachusetts |
Aav capsids identified by in vivo library selection
|
|
JP2021530227A
(ja)
|
2018-07-13 |
2021-11-11 |
アコーオス インコーポレイテッド |
非症候性感音性聴力喪失の治療方法
|
|
US12467064B2
(en)
|
2018-10-08 |
2025-11-11 |
Allen Institute |
Artificial expression constructs for selectively modulating gene expression in interneurons
|
|
US12391947B2
(en)
|
2018-11-29 |
2025-08-19 |
University Of Massachusetts |
Modulation of SPTLC1 via recombinant adeno-associated vectors
|
|
CA3131023A1
(en)
|
2019-02-22 |
2020-08-27 |
Michael R. Volkert |
Oxr1 gene therapy
|
|
CN113710693B
(zh)
|
2019-02-25 |
2025-07-15 |
马萨诸塞大学 |
Dna结合结构域反式激活因子及其用途
|
|
WO2020210705A1
(en)
|
2019-04-12 |
2020-10-15 |
University Of Massachusetts |
Aav-cas13d vectors and uses thereof
|
|
US12553036B2
(en)
|
2019-04-12 |
2026-02-17 |
University Of Massachusetts |
GM3 synthase vectors and uses thereof
|
|
CN114555814A
(zh)
|
2019-09-13 |
2022-05-27 |
罗特格斯新泽西州立大学 |
Aav相容的层粘连蛋白-连接子聚合蛋白
|
|
US12485166B2
(en)
|
2020-02-06 |
2025-12-02 |
Longhorn Vaccines And Diagnostics, Llc |
Vaccines for the treatment and prevention of zoonotic infections
|
|
CA3168055A1
(en)
|
2020-02-21 |
2021-08-26 |
Emmanuel John Simons |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
US20230089312A1
(en)
|
2020-02-25 |
2023-03-23 |
University Of Massachusetts |
Inducible single aav system and uses thereof
|
|
BR112022019304A2
(pt)
|
2020-03-31 |
2022-12-06 |
Univ Massachusetts |
Variantes de capsídeo de aav e usos das mesmas
|
|
CN115803084A
(zh)
|
2020-05-21 |
2023-03-14 |
得克萨斯大学体系董事会 |
具有vgll1特异性的t细胞受体和其用途
|
|
IL300526A
(en)
|
2020-08-17 |
2023-04-01 |
Massachusetts Inst Technology |
Approaches to SHANK3 gene therapy
|
|
JP7173415B2
(ja)
*
|
2020-08-19 |
2022-11-16 |
東洋インキScホールディングス株式会社 |
貼付剤
|
|
KR20230091978A
(ko)
|
2020-10-20 |
2023-06-23 |
롱혼 백신즈 앤드 다이어그나스틱스, 엘엘씨 |
면역원성 항원
|
|
US12310928B2
(en)
|
2020-11-16 |
2025-05-27 |
University Of Utah Research Foundation |
Enthesis healing
|
|
EP4255457A4
(de)
|
2020-12-03 |
2025-05-21 |
University of Massachusetts |
Entwicklung von neuen gentherapeutika für fibrodysplasia ossificans progressiva
|
|
WO2022159722A1
(en)
|
2021-01-22 |
2022-07-28 |
University Of Massachusetts |
Use of novel mirna-binding site cassettes for antigen-presenting cell detargeting of transgene expression by raav gene therapy vectors
|
|
AU2022272489A1
(en)
|
2021-05-10 |
2023-11-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Pharmaceutical compositions for treating neurological conditions
|
|
US20250288692A1
(en)
|
2021-09-30 |
2025-09-18 |
Akouos, Inc. |
Compositions and methods for treating kcnq4-associated hearing loss
|
|
EP4437113A4
(de)
|
2021-11-23 |
2026-04-08 |
Univ Massachusetts |
Gentherapie für spinale muskelatrophie
|
|
EP4482970A1
(de)
|
2022-02-23 |
2025-01-01 |
Massachusetts Institute of Technology |
Verfahren zur hochregulierung der expression von shank3
|
|
WO2024196965A1
(en)
|
2023-03-23 |
2024-09-26 |
Carbon Biosciences, Inc. |
Parvovirus compositions and related methods for gene therapy
|
|
US12383615B2
(en)
|
2023-03-23 |
2025-08-12 |
Carbon Biosciences, Inc. |
Protoparvovirus compositions comprising a protoparvovirus variant VP1 capsid polypeptide and related methods
|
|
CN121794288A
(zh)
|
2023-05-05 |
2026-04-03 |
麻省理工学院 |
Shank3基因治疗方法
|
|
WO2026072721A1
(en)
|
2024-09-25 |
2026-04-02 |
Carbon Biosciences, Inc. |
Parvovirus compositions and methods for gene therapy
|